Genetics in rheumatoid arthritis beyond HLA genes: What meta-analyses have shown?

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 1, 2013, Pages 29-38

  Chatzikyriakidou, Anthoula ^a,b   Voulgari, Paraskevi V ^b   Lambropoulos, Alexandros ^a   Drosos, Alexandros A ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Gene; Meta analysis; Polymorphism; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; HLA ANTIGEN; NEW DRUG;

6Q23 GENE; 8Q24 GENE; ARTICLE; BIOINFORMATICS; BLK GENE; CCL21 GENE; CCR5 GENE; CD226 GENE; CD244 GENE; CD247 GENE; CD40 GENE; CDK6 GENE; CFH GENE; COMPUTER PROGRAM; CTLA4 GENE; DCIR GENE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FAS GENE; FCGR3A GENE; FCGR3B GENE; FCRL3 GENE; GENE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETICS; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HLA GENE; HUMAN; IL 10 GENE; IL 18 GENE; IL 1B GENE; IL 1RA GENE; IL 2 GENE; IL 21 GENE; IL 2RA GENE; IL 2RB GENE; IL 6 GENE; IRF5 GENE; ITGAV GENE; KIF5A GENE; KLF12 GENE; LPP GENE; MBL2 GENE; MBP GENE; MHC2TA GENE; MIF GENE; MMEL1 GENE; P53 GENE; PADI4 GENE; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PRL GENE; PTGES GENE; PTPN22 GENE; PXK GENE; REL GENE; RHEUMATOID ARTHRITIS; SH2B3 GENE; SLC22A4 GENE; STAT4 GENE; SUMO4 GENE; TLR5 GENE; TLR7 GENE; TNFAIP3 GENE; TRAF1 GENE; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; UBASH3A GENE; UBE2L3 GENE; VDR GENE;

GENE; META-ANALYSIS; POLYMORPHISM; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; META-ANALYSIS AS TOPIC; POLYMORPHISM, GENETIC;

EID: 84881552086     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.12.003     Document Type: Article

References (87)

1. Iguchi T., Ziff M. Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest 1986, 77:355-361.
2. FitzGerald O., Soden M., Yanni G., Robinson R., Bresnihan B. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis 1991, 50:792-796.
3. Alamanos Y., Voulgari P.V., Drosos A.A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006, 36:182-188.
4. Alamanos Y., Drosos A.A. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005, 4:130-136.
5. Coenen M.J., Gregersen P.K. Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun 2009, 10:101-111.
6. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
7. Deighton C.M., Walker D.J., Griffiths I.D., Roberts D.F. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989, 36:178-182.
8. Bax M., van Heemst J., Huizinga T.W., Toes R.E. Genetics of rheumatoid arthritis: what have we learned?. Immunogenetics 2011, 63:459-466.
9. Li X., Zhang C., Zhang J., Zhang Y., Wu Z., Yang L., et al. Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis. J Clin Immunol 2012, 32:530-539.
10. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39:5599-5605.
11. Daha N.A., Kurreeman F.A.S., Marques R.B., Stoeken-Rijsbergen G., Verduijn W., Huizinga T.W.J., et al. Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum 2009, 60:1255-1260.
12. Han S., Li Y., Mao Y., Xie Y. Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis. Hum Genet 2005, 118:123-132.
13. Lei C., Dongqing Z., Yeqing S., Oaks M.K., Lishan C., Jianzhong J., et al. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur J Hum Genet 2005, 13:823-828.
14. Plant D., Flynn E., Mbarek H., Dieudé P., Cornelis F., Ärlestig L., et al. Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 2010, 69:1548-1553.
15. Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008, 40:1216-1223.
16. Ren K.W., Mi Y.Y., Xu N.W. Reply: clarification of data for a recent meta-analysis: meta-analysis of PTPN22 1858C/T polymorphism and rheumatoid arthritis risk in Europeans. Arch Med Res 2012, 43:172.
17. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. The association between the PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis update. Mol Biol Rep 2012, 39:3453-3460.
18. Nong L.M., Ren K.W., Xu N.W., Zhou D. C/T polymorphism of the protein tyrosine phosphatase nonreceptor 22 gene and rheumatoid arthritis risk in europeans: a meta-analysis. Arch Med Res 2011, 42:698-702.
19. Totaro M.C., Tolusso B., Napolioni V., Faustini F., Canestri S., Mannocci A., et al. PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis. PLoS One 2011, 6:e24292.
20. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G., Nath S.K., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology 2007, 46:49-56.
21. Coenen M.J., Trynka G., Heskamp S., Franke B., van Diemen C.C., Smolonska J., et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 2009, 18:4195-4203.
22. Ramirez M., Quintana G., Diaz-Gallo L.M., Caminos J., Garces M., Cepeda L., et al. The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population. Clin Exp Rheumatol 2012, 30:520-524.
23. Suarez-Gestal M., Calaza M., Dieguez-Gonzalez R., Perez-Pampin E., Pablos J.L., Navarro F., et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheum 2009, 60:2558-2564.
24. Lee Y.H., Woo J.H., Choi S.J., Ji J.D., Song G.G. Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis. Rheumatol Int 2010, 30:661-666.
25. Ji J.D., Lee W.J., Kong K.A., Woo J.H., Choi S.J., Lee Y.H., et al. Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2010, 37:141-147.
26. Zhernakova A., Stahl E.A., Trynka G., Raychaudhuri S., Festen E.A., Franke L., et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011, 7:e1002004.
27. Orozco G., Alizadeh B.Z., Delgado-Vega A.M., González-Gay M.A., Balsa A., Pascual-Salcedo D., et al. Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. Arthritis Rheum 2008, 58:1974-1980.
28. Liang Y.L., Wu H., Shen X., Li P.Q., Yang X.Q., Liang L., et al. Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis. Mol Biol Rep 2012, 39:8873-8882.
29. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G. PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 2007, 27:827-833.
30. Takata Y., Inoue H., Sato A., Tsugawa K., Miyatake K., Hamada D., et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 2008, 53:163-173.
31. Iwamoto T., Ikari K., Nakamura T., Kuwahara M., Toyama Y., Tomatsu T., et al. Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology 2006, 45:804-807.
32. Burr M.L., Naseem H., Hinks A., Eyre S., Gibbons L.J., Bowes J., et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 2010, 69:666-670.
33. Hou S., Gao G.P., Zhang X.J., Sun L., Peng W.J., Wang H.F., et al. PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mod Rheumatol 2012, [Epub ahead of print].
34. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 2012, 61:665-671.
35. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39:81-87.
36. Zhang J., Zhang Y., Jin J., Li M., Xie K., Wen C., et al. The -1082A/G polymorphism in the interleukin-10 gene and the risk of rheumatoid arthritis: a meta-analysis. Cytokine 2011, 56:351-355.
37. Maiti A.K., Kim-Howard X., Viswanathan P., Guillén L., Rojas-Villarraga A., Deshmukh H., et al. Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum 2010, 62:323-329.
38. Hollis-Moffatt J.E., Chen-Xu M., Topless R., Dalbeth N., Gow P.J., Harrison A.A., et al. Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance. Arthritis Res Ther 2010, 12:R116.
39. Harrison P., Pointon J.J., Chapman K., Roddam A., Wordsworth B.P. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology 2008, 47:1768-1770.
40. Lee Y.H., Ji J.D., Song G.G. Association between interleukin 1 polymorphisms and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 2009, 36:12-15.
41. Song G.G., Bae S.C., Choi S.J., Ji J.D., Lee Y.H. Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39:10655-10663.
42. Hollis-Moffatt J.E., Merriman M.E., Rodger R.A., Rowley K.A., Chapman P.T., Dalbeth N., et al. Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis. Ann Rheum Dis 2009, 68:1340-1344.
43. Chen-Xu M., Topless R., McKinney C., Merriman M.E., Phipps-Green A., Dalbeth N., et al. Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets. Ann Rheum Dis 2012, 71:155-157.
44. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 2012, 61:635-641.
45. Bowes J., Lawrence R., Eyre S., Panoutsopoulou K., Orozco G., Elliott K.S., et al. Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis. Hum Genet 2010, 128:627-633.
46. Thabet M.M., Wesoly J., Slagboom P.E., Toes R.E., Huizinga T.W. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007, 66:803-806.
47. Begovich A.B., Chang M., Schrodi S.J. Meta-analysis evidence of a differential risk of the FCRL3 -169T->C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 2007, 56:3168-3171.
48. Lee Y.H., Woo J.H., Choi S.J., Ji J.D., Song G.G. Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis. Rheumatol Int 2010, 30:947-953.
49. Du Y., Shen L.X., Yu L.K., Song Y., Zhu J.F., Du R. The CD226 gene in susceptibility of rheumatoid arthritis in the Chinese Han population. Rheumatol Int 2012, 32:1299-1304.
50. Song G.G., Bae S.C., Choi S.J., Ji J.D., Lee Y.H. Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Lupus 2012, 21:1522-1530.
51. Qiu Z.X., Zhang K., Qiu X.S., Zhou M., Li W.M. CD226 Gly307Ser association with multiple autoimmune diseases: a meta-analysis. Hum Immunol 2012, [Epub ahead of print].
52. Orozco G., Eyre S., Hinks A., Ke X. Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study. Ann Rheum Dis 2010, 69:813-816. Wellcome Trust Case Control consortium YEAR Consortium, Wilson AG, Bax DE, et al.
53. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42:508-514.
54. Terao C., Ohmura K., Katayama M., Takahashi M., Kokubo M., Diop G., et al. Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis-a genome-wide study combined with immunological analyses. PLoS One 2011, 6:e20457.
55. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2011, 38:3643-3651.
56. Orozco G., Eyre S., Hinks A., Bowes J., Morgan A.W., Wilson A.G., et al. Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2011, 70:463-468.
57. Chang W.W., Su H., He L., Zhao K.F., Wu J.L., Xu Z.W. Association between transforming growth factor-beta1 T869C polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatology 2010, 49:652-656.
58. Lee Y.C., Raychaudhuri S., Cui J., De Vivo I., Ding B., Alfredsson L., et al. The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility. Arthritis Rheum 2009, 60:1250-1254.
59. Dieguez-Gonzalez R., Calaza M., Perez-Pampin E., de la Serna A.R., Fernandez-Gutierrez B., Castañeda S., et al. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum 2008, 58:1264-1274.
60. Han S.W., Lee W.K., Kwon K.T., Lee B.K., Nam E.J., Kim G.W. Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: a metaanalysis. J Rheumatol 2009, 36:693-697.
61. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between interferon regulatory factor 5 polymorphisms and rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, [Epub ahead of print].
62. Varadé J., Palomino-Morales R., Ortego-Centeno N., Díaz-Rubio M., Fernández-Gutiérrez B., González-Gay M.Á., et al. Analysis of the REL polymorphism rs13031237 in autoimmune diseases. Ann Rheum Dis 2011, 70:711-712.
63. Korotkova M., Daha N.A., Seddighzadeh M., Ding B., Catrina A.I., Lindblad S., et al. Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis. Eur J Hum Genet 2011, 19:908-914.
64. Bronson P.G., Criswell L.A., Barcellos L.F. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann Rheum Dis 2008, 67:933-936.
65. Eike M.C., Skinningsrud B., Ronninger M., Stormyr A., Kvien T.K., Joner G., et al. CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations. Genes Immun 2012, 13:431-436.
66. Plant D., Barton A., Thomson W., Ke X., Eyre S., Hinks A., et al. A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis. Ann Rheum Dis 2009, 68:1373-1375.
67. Okada Y., Mori M., Yamada R., Suzuki A., Kobayashi K., Kubo M., et al. SLC22A4 polymorphism and rheumatoid arthritis susceptibility: a replication study in a Japanese population and a metaanalysis. J Rheumatol 2008, 35:1723-1728.
68. Lee Y.H., Ji J.D., Song G.G. Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis. J Rheumatol 2008, 35:2129-2135.
69. Guo J., Wu X., Too C.L., Yin F., Lu X., He J., et al. A replication study confirms the association of dendritic cell immunoreceptor (DCIR) polymorphisms with ACPA-negative RA in a large Asian cohort. PLoS One 2012, 7:e41228.
70. Xie Q., Wang S.C., Bian G., Zhan F.L., Xie J.K., Li J. Association of MIF -173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: a meta-analysis. Hum Immunol 2012, 73:966-971.
71. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between the FAS -670 A/G and -1377 G/A polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis. Mol Biol Rep 2012, 39:10671-10679.
72. Patsopoulos N.A., Ioannidis J.P. Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis. Ann Rheum Dis 2010, 69:561-566.
73. Pan H.F., Leng R.X., Ye D.Q. Lack of association of interleukin-18 gene promoter -607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Lupus 2011, 20:945-951.
74. Chen S., Jiang F., Ren J., Liu J., Meng W. Association of IL-18 polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Asian populations: a meta-analysis. BMC Med Genet 2012, 13:107.
75. Xue J., Mou L., Lu X., Wu H. No association of interleukin-1 receptor antagonist VNTR polymorphism and rheumatoid arthritis susceptibility: a meta analysis. Clin Exp Rheumatol 2010, 28:654-660.
76. Prahalad S. Negative association between the chemokine receptor CCR5-delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun 2006, 7:264-268.
77. Lindner E., Nordang G.B., Melum E., Flatø B., Selvaag A.M., Thorsby E., et al. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. BMC Med Genet 2007, 8:33.
78. Lee Y.H., Bae S.C., Song G.G. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Mod Rheumatol 2012, [Epub ahead of print].
79. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between the p53 codon 72 polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. Lupus 2012, 21:430-437.
80. García-Bermúdez M., López-Mejias R., Rodriguez-Rodriguez L., Fernández-Gutierrez B., García A., Raya E., et al. No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data. Hum Immunol 2011, 72:779-782.
81. Coenen M.J., Enevold C., Barrera P., Schijvenaars M.M., Toonen E.J., Scheffer H., et al. Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS One 2010, 5:e14326.
82. Zou Y.F., Feng X.L., Tao J.H., Zhu J.M., Pan F.M., Su H., et al. Association of SUMO4 M55V polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Int J Immunogenet 2010, 37:345-354.
83. Hollis-Moffatt J.E., Rowley K.A., Phipps-Green A.J., Merriman M.E., Dalbeth N., Gow P., et al. The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets. Arthritis Res Ther 2009, 11:R152.
84. Trouw L.A., Böhringer S., Daha N.A., Stahl E.A., Raychaudhuri S., Kurreeman F.A., et al. The major risk alleles of age-related macular degeneration (AMD) in CFH do not play a major role in rheumatoid arthritis (RA). Clin Exp Immunol 2011, 166:333-337.
85. Chen J., Huang F., Liu M., Duan X., Xiang Z. Genetic polymorphism of glutathione S-transferase T1 and the risk of rheumatoid arthritis: a meta-analysis. Clin Exp Rheumatol 2012, 30:741-747.
86. Song G.G., Bae S.C., Lee Y.H. The glutathione S-transferase M1 and P1 polymorphisms and rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39:10739-10745.
87. Lee Y.H., Ji J.D., Song G.G. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 2007, 34:43-49.